[1] S. H. Daukes, “A Consideration of the Various Methods of Drug Administration,” Post Graduate Medical Journal, Vol. 5, No. 49, 1929, pp. 1-7. doi:10.1136/pgmj.5.49.1
[2] J. Smieja, et al., “Optimal Control for the Model of Drug Resistance Resulting from Gen Amplification,” Preperation of the 14th IFAC World Congress, Beijing, China, Vol. 50, 1999, pp. 71-75.
[3] A. Swierniak et al., “Asymptotic Properties of Infinite Dimensional Model Drug Resistance Evolution,” Proceedings of the European Control Conference (ECC), Brussels, 1997.
[4] W. E. Evans and H. L. McLeod, “Pharmacogenomics— drug disposition, drug targets, and side effects,” New England Journal of Medicine, Vol. 348, No. 6, 2003, pp. 538-549. doi:10.1056/NEJMra020526
[5] C. Abad-Zapatero and J. T. Metz, “Ligand Efficiency In- dices as Guideposts for Drug Discovery,” Drug Discovery Today, Vol. 10, No. 7, 2005, pp. 464-469. doi:10.1016/S1359-6446(05)03386-6
[6] C. Hetenyi, et al., “Structure-Based Calculation of Drug Efficiency Indices,” Journal of Structural Bioinformatics, Vol. 23, No. 20, 2007, pp. 2678-2685. doi:10.1093/bioinformatics/btm431
[7] P. Tirupathi Rao and R. Bharathi, “Stochastic Modeling in the Evaluation of Drug Efficiency,” International Journal of Statistics and System, Vol. 5, No. 3, 2010, pp. 427-438.